Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
<p><strong>Background</strong> Antidepressants are licensed for use in depressive disorders, but non-response and poor adherence to treatment affect a considerable number of patients. Pre-clinical and clinical evidence suggest that statins can augment the effects of antidepressants...
Main Authors: | De Giorgi, R, De Crescenzo, F, Cowen, PJ, Harmer, CJ, Cipriani, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2023
|
Similar Items
-
Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
by: Riccardo De Giorgi, et al.
Published: (2023-11-01) -
Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study
by: De Giorgi, R, et al.
Published: (2024) -
Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study
by: De Giorgi, R, et al.
Published: (2024) -
Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study
by: Andrea Cipriani, et al.
Published: (2024-05-01) -
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
by: De Giorgi, R, et al.
Published: (2022)